Valrubicin (Valstar) is an anthracycline chemotherapy drug used to treat bladder cancer. It is a type of chemotherapy drug called an anthracycline. It works by killing cancer cells or stopping them from multiplying. Valrubicin is usually given through a catheter directly into your bladder. It is usually given once a week for six weeks. Common side effects of Valrubicin include nausea, vomiting, diarrhea, fatigue, and hair loss.
Valrubicin is a chemotherapy medication used specifically to treat a type of bladder cancer. Here's a closer look at its key features:
Function: Valrubicin belongs to a class of drugs called anthracyclines. It works by interfering with the growth and division of cancer cells.
Use: Valrubicin is used to treat a specific type of bladder cancer called carcinoma in situ (CIS) that has not responded well to another medication called Bacillus Calmette-Guerin (BCG) therapy. It's typically used only when surgery to remove part or all of the bladder is not a suitable option for the patient.
Administration: Valrubicin is administered directly into the bladder through a catheter (a thin, flexible tube). This is called intravesical administration.
Important Considerations:
- Valrubicin has limited effectiveness, with only about 1 in 5 patients responding to treatment.
- Delaying surgery to try valrubicin may increase the risk of the cancer spreading. The decision to use valrubicin should be carefully weighed by you and your doctor.
- Valrubicin can cause side effects, including burning or irritation in the bladder, blood in the urine, and frequent urination.
- It's crucial to discuss any allergies or medical conditions you have with your doctor before receiving valrubicin.
Additional Information:
- Valrubicin was originally withdrawn from the market due to manufacturing issues but has since been reintroduced.
- There are other treatment options available for bladder cancer, and your doctor will recommend the most suitable one based on the specific details of your case.